slides · global inventory
Source Note
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,355
Current window 58,591-58,620
Pages 3,679
Rows per page 30
Component
58,591-58,620 of 110,355
60
LSE | Investor Day Presentation Deck | 100 slidesLSE | Investor Day Presentation Deck | 100 slides · LSEG
Conference presentation Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
61
The slide uses a visual representation of market growth from 2020 to 2025.LSE | Investor Day Presentation Deck | 100 slides · LSEG
Conference presentation Investor relations Beat · Financials1 hit
64
The slide uses a stacked bar chart to illustrate revenue composition and CAGR trends.LSE | Investor Day Presentation Deck | 100 slides · LSEG
Conference presentation Investor relations Beat · Financials1 hit
65
The slide uses a matrix structure to compare business segments against strategic attributes.LSE | Investor Day Presentation Deck | 100 slides · LSEG
Conference presentation Investor relations Beat · Financials1 hit
81
LSE | Investor Day Presentation Deck | 100 slidesLSE | Investor Day Presentation Deck | 100 slides · LSEG
Conference presentation Investor relations 1 hit
82
Uses a visual bridge/arrow to connect drivers to market growth.LSE | Investor Day Presentation Deck | 100 slides · LSEG
Conference presentation Investor relations 1 hit
84
LSE | Investor Day Presentation Deck | 100 slidesLSE | Investor Day Presentation Deck | 100 slides · LSEG
Conference presentation Investor relations 1 hit
85
Slide provides a structured breakdown of business segments with associated KPIs and competitive landscape.LSE | Investor Day Presentation Deck | 100 slides · LSEG
Conference presentation Investor relations 1 hit
93
The chart shows a trend line with +11% CAGR.LSE | Investor Day Presentation Deck | 100 slides · LSEG
Conference presentation Investor relations 1 hit
05
The slide uses a split-layout comparing the company's mission/context on the left with the specific product value proposition and market statistics on the right.Mainz Biomed NV | Investor Presentation Deck | 23 slides · Mainz Biomed
Pitch deck Investor relations Beat · Problem1 hit
07
The slide uses a series of circular metrics to quantify the total addressable market and the urgency of the problem.Mainz Biomed NV | Investor Presentation Deck | 23 slides · Mainz Biomed
Pitch deck Investor relations Beat · Agitate1 hit
08
Includes a comparison to Exact Sciences' ColoGuard as a market positioning anchor.Mainz Biomed NV | Investor Presentation Deck | 23 slides · Mainz Biomed
Pitch deck Investor relations Beat · Solution1 hit
11
The slide uses a bulleted list to detail the partnership strategy, focusing on leveraging existing lab infrastructure to minimize marketing overhead.Mainz Biomed NV | Investor Presentation Deck | 23 slides · Mainz Biomed
Pitch deck Investor relations Beat · ActionLoop · Quick Win Big Bet1 hit
21
Includes a disclaimer at the bottom and a citation for the 85% detection rate.Mainz Biomed NV | Investor Presentation Deck | 23 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
10
The slide features a 3D molecular rendering showing the inhibitor (pink) bound to the target protein (blue).Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank 1 hit
11
The slide uses a three-part process flow to explain the biological mechanism of ROS1-driven disease and resistance.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank 1 hit
12
The table highlights the clinical limitations of current standard-of-care drugs (Crizotinib, Entrectinib) due to resistance mutations like G2032R and CNS involvement.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank Beat · Market Sizing1 hit
14
The slide uses a medical illustration to map specific TRK receptor inhibition (TRKB, TRKC, TRKA) to corresponding neurological and physiological side effects.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank Beat · Competition1 hit
16
Includes a table of IC50 values and a line chart showing tumor volume over time for different dosages.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank 1 hit
17
Includes a heatmap table for IC50 values and two line charts showing tumor volume reduction in PDX models.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank 1 hit
18
The chart uses a logarithmic scale to show relative selectivity ratios.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank 1 hit
19
The kinome tree is a standard visualization in pharmacology for kinase selectivity.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank 1 hit
21
The slide uses bioluminescence imaging to show tumor reduction and a Kaplan-Meier survival curve to show efficacy.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank 1 hit
25
The slide uses a three-column process flow to explain the biological mechanism of ALK-driven cancer and resistance.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank 1 hit
26
The slide highlights the clinical unmet need as patients progress through lines of therapy, specifically noting resistance mutations and CNS involvement.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
29
The slide uses a color-coded heatmap to indicate potency (green for high potency, yellow for lower).Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank 1 hit
30
Includes a table of IC50 values and two line charts showing tumor volume reduction in CDX models.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank 1 hit
31
The chart uses a logarithmic scale to show fold-selectivity. NVL-655 shows significantly higher selectivity for ALK variants compared to the other two drugs.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank 1 hit
32
The slide uses a kinome tree diagram to visualize selectivity. The table defines the selectivity index based on IC50 ratios.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank 1 hit
36
The slide uses a side-by-side comparison structure to highlight the target product profiles for ALK IXDN Resistance Mutations and HER2 Exon 20 Insertions.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank 1 hit